Citation: C. Oberhoff et al., ADJUVANT TAMOXIFEN TREATMENT IN BREAST-CANCER INDUCES NO ACTIVATION OF BLOOD-COAGULATION, European journal of cancer, 34, 1998, pp. 14-14
Citation: C. Oberhoff et al., BLOOD-COAGULATION AND FIBRINOLYSIS AFTER ORAL OR INTRAVENOUS CYCLOPHOSPHAMIDE CONTAINING ADJUVANT CMF-CHEMOTHERAPY, European journal of cancer, 34, 1998, pp. 15-15
Authors:
OBERHOFF C
SZYMECZEK J
HOFFMANN O
WINKLER UH
KAISER S
SCHINDLER AE
Citation: C. Oberhoff et al., ADJUVANT ANTIESTROGEN TREATMENT WITH TAMOXIFEN IN POSTMENOPAUSAL WOMEN WITH BREAST-CANCER - A LONGITUDINAL-STUDY OF BLOOD-COAGULATION AND FIBRINOLYSIS, Breast cancer research and treatment, 50(1), 1998, pp. 73-81
Citation: Uh. Winkler, DIAGNOSIS AND MANAGEMENT OF THROMBOEMBLIC DISORDERS DURING PREGNANCY,DELIVERY AND PUERPERIUM - REPLY, Der Gynakologe, 31(2), 1998, pp. 183-183
Authors:
WINKLER UH
HOWIE H
BUHLER K
KORVER T
GEURTS TBP
BENNINK HJTC
Citation: Uh. Winkler et al., A RANDOMIZED CONTROLLED DOUBLE-BLIND-STUDY OF THE EFFECTS ON HEMOSTASIS OF 2 PROGESTOGEN-ONLY PILLS CONTAINING 75-MU-G DESOGESTREL OR 30-MU-G LEVONORGESTREL, Contraception, 57(6), 1998, pp. 385-392
Citation: Uh. Winkler, EFFECTS ON HEMOSTATIC VARIABLES OF DESOGESTREL-CONTAINING AND GESTODENE-CONTAINING ORAL-CONTRACEPTIVES IN COMPARISON WITH LEVONORGESTREL-CONTAINING ORAL-CONTRACEPTIVES - A REVIEW, American journal of obstetrics and gynecology, 179(3), 1998, pp. 51-61
Citation: Laj. Heinemann et al., SCIENTIFIC PROBLEMS WITH A NONCAUSAL ARTIFACT, American journal of obstetrics and gynecology, 178(5), 1998, pp. 1105-1106
Authors:
WINKLER UH
PARK JW
WEBER S
KOTHE A
SCHNITKER J
BEHRENDSSTEINS B
ALBRING M
Citation: Uh. Winkler et al., ACTIVATION OF BLOOD-CLOTTING AND FIBRINOL YSIS IN ANGIOCARDIOGRAPHY WITH IONIC AND NONIONIC CONTRAST-MEDIUM, RoFo. Fortschritte auf dem Gebiete der Rontgenstrahlen und der neuenbildgebenden Verfahren, 166(6), 1997, pp. 539-543
Citation: Uh. Winkler, DIAGNOSIS AND MANAGEMENT OF THROMBOEMBOLIC DISORDERS DURING PREGNANCY, DELIVERY AND PUEPERIUM, Der Gynakologe, 30(9), 1997, pp. 712-719
Authors:
WINKLER UH
HOLSCHER T
SCHULTE H
ZIERLEYN JP
COLLET W
SCHINDLER AE
Citation: Uh. Winkler et al., ETHINYLESTRADIOL-20 VERSUS 30-MU-G COMBINED WITH 150-MU-G DESOGESTREL- A LARGE COMPARATIVE-STUDY OF THE EFFECTS OF 2 LOW-DOSE ORAL-CONTRACEPTIVES ON THE HEMOSTATIC SYSTEM, Gynecological endocrinology, 10(4), 1996, pp. 265-271
Citation: Uh. Winkler et Ae. Schindler, PROPHYLAXIS AND TREATMENT OF THROMBOEMBOL ISM DURING PREGNANCY, Geburtshilfe und Frauenheilkunde, 56(6), 1996, pp. 301-312
Authors:
WINKLER UH
SCHINDLER AE
ENDRIKAT J
DUSTERBERG B
Citation: Uh. Winkler et al., A COMPARATIVE-STUDY OF THE EFFECTS OF THE HEMOSTATIC SYSTEM OF 2 MONOPHASIC GESTODENE ORAL-CONTRACEPTIVES CONTAINING 20 MU-G AND 30 MU-G ETHINYLESTRADIOL, Contraception, 53(2), 1996, pp. 75-84
Authors:
WINKLER UH
OBERHOFF C
BIER U
SCHINDLER AE
GILLAIN D
Citation: Uh. Winkler et al., HEMOSTATIC EFFECTS OF 2 ORAL-CONTRACEPTIVES CONTAINING LOW-DOSES OF ETHINYL ESTRADIOL AND EITHER GESTODENE OR NORGESTIMATE - AN OPEN, RANDOMIZED, PARALLEL-GROUP STUDY, International journal of fertility and menopausal studies, 40(5), 1995, pp. 260-268
Authors:
OBERHOFF C
KRUMMEICH B
WINKLER UH
SCHINDLER AE
Citation: C. Oberhoff et al., ERYTHROPOIETIN AND CHEMOTHERAPY - EFFECTS ON HEMOSTASIS AND FIBRINOLYSIS, European journal of cancer, 31A, 1995, pp. 1245-1245
Authors:
WINKLER UH
HOLSCHER T
OBERHOFF C
SCHINDLER AE
Citation: Uh. Winkler et al., ORAL CONTRACEPTION AND COAGULATION ACTIVI TY - THROMBOGENIC ACTIVITY OF SYNTHETIC STEROIDS, Archives of gynecology and obstetrics, 254(1-4), 1993, pp. 306-307